Veteran Oncology Researcher to Guide Investment in Breakthrough Cancer Treatments
LOS ANGELES, July 10, 2023 /PRNewswire/ -- Stand Up To Cancer® (SU2C) today announced that Julian Adams, Ph.D., a longtime oncology researcher and retired pharmaceutical industry chief executive, was named the organization's first Chief Science Officer.
Read more at prnewswire.com